Titlebook: Biologic Therapy of Leukemia; Matt Kalaycio Book 2003 Springer Science+Business Media New York 2003 antibody.cytokine.cytokines.dendritic

显示全部楼层 · 发表于 2025-3-21 16:11:33

书目名称Biologic Therapy of Leukemia影响因子(影响力)

书目名称Biologic Therapy of Leukemia影响因子(影响力)学科排名

书目名称Biologic Therapy of Leukemia网络公开度

书目名称Biologic Therapy of Leukemia网络公开度学科排名

书目名称Biologic Therapy of Leukemia被引频次

书目名称Biologic Therapy of Leukemia被引频次学科排名

书目名称Biologic Therapy of Leukemia年度引用

书目名称Biologic Therapy of Leukemia年度引用学科排名

书目名称Biologic Therapy of Leukemia读者反馈

书目名称Biologic Therapy of Leukemia读者反馈学科排名

显示全部楼层 · 发表于 2025-3-21 23:46:51

Radiolabeled Monoclonal Antibodies-mediated cytotoxicity (ADCC), in which an effector cell expressing an Fc receptor binds to a cell-bound MAb and is triggered to kill the target cell. Examples of antibodies with intrinsic immunologically mediated antitumor activity include the chimeric anti-CD20 antibody rituximab . and the humaniz

显示全部楼层 · 发表于 2025-3-22 00:23:28

显示全部楼层 · 发表于 2025-3-22 07:33:16

显示全部楼层 · 发表于 2025-3-22 12:39:12

显示全部楼层 · 发表于 2025-3-22 13:21:34

显示全部楼层 · 发表于 2025-3-22 18:17:06

显示全部楼层 · 发表于 2025-3-22 23:53:16

Franz J. Frei,Thomas Erb,Robert Sümpelmann in their eradication. The . Web site currently lists 596 clinical trials initiated since 1989, including 376 (63%) that are related to the treatment of malignancies, with 2389 patients enrolled in cancer-related gene therapy protocols .. A total of 46 (8%) of all gene therapy trials focus on the tr

显示全部楼层 · 发表于 2025-3-23 01:42:45

Human Leukemia-Derived Dendritic Cells as Tools for Therapy such as the recently developed tyrosine kinase inhibitor Imatinib Mesylate, may fail to control advanced forms of the target disease .. Additionally, for many human leukemias, no such well-defined genetic background is available at present. Accordingly, efforts to advance the therapy for these diseases must focus on other approaches.

显示全部楼层 · 发表于 2025-3-23 09:19:53

Interleukin-2 Treatment of Acute Leukemia(AML), 60–80% of patients will initially achieve complete remission (CR) but the majority of them will relapse .. Only 10%–30% of patients achieve prolonged leukemia-free survival .. In the case of acute lymphocytic leukemia (ALL), 60–65% of children can achieve long-term survival but only 10–30% of adults survive 5 yr free of recurrence ..

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-11 23:32
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

Titlebook: Biologic Therapy of Leukemia; Matt Kalaycio Book 2003 Springer Science+Business Media New York 2003 antibody.cytokine.cytokines.dendritic

浏览过的版块